Author
Listed:
- Daniela Rovito
(Institut de Génétique et de Biologie Moléculaire et Cellulaire
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale (INSERM)
Université de Strasbourg)
- Anna Y. Belorusova
(Medicinal Chemistry, Respiratory, Inflammation and Autoimmunity, BioPharmaceuticals R&D, AstraZeneca)
- Sandra Chalhoub
(Institut de Génétique et de Biologie Moléculaire et Cellulaire
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale (INSERM)
Université de Strasbourg)
- Anna-Isavella Rerra
(Institut de Génétique et de Biologie Moléculaire et Cellulaire
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale (INSERM)
Université de Strasbourg)
- Elvire Guiot
(Institut de Génétique et de Biologie Moléculaire et Cellulaire
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale (INSERM)
Université de Strasbourg)
- Arnaud Molin
(Université de Normandie, UNICAEN, CHU de Caen Normandie, Service de Génétique
Reference Center for Rare Diseases of Calcium and Phosphorus Metabolism (OSCAR))
- Agnès Linglart
(Reference Center for Rare Diseases of Calcium and Phosphorus Metabolism (OSCAR)
Université de Paris Saclay, AP-HP, Hôpital Bicêtre, DMU SEA, INSERM, U1185)
- Natacha Rochel
(Institut de Génétique et de Biologie Moléculaire et Cellulaire
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale (INSERM)
Université de Strasbourg)
- Gilles Laverny
(Institut de Génétique et de Biologie Moléculaire et Cellulaire
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale (INSERM)
Université de Strasbourg)
- Daniel Metzger
(Institut de Génétique et de Biologie Moléculaire et Cellulaire
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale (INSERM)
Université de Strasbourg)
Abstract
The bioactive vitamin D3, 1α,25(OH)2D3, plays a central role in calcium homeostasis by controlling the activity of the vitamin D receptor (VDR) in various tissues. Hypercalcemia secondary to high circulating levels of vitamin D3 leads to hypercalciuria, nephrocalcinosis and renal dysfunctions. Current therapeutic strategies aim at limiting calcium intake, absorption and resorption, or 1α,25(OH)2D3 synthesis, but are poorly efficient. In this study, we identify WBP4 as a new VDR interactant, and demonstrate that it controls VDR subcellular localization. Moreover, we show that the vitamin D analogue ZK168281 enhances the interaction between VDR and WBP4 in the cytosol, and normalizes the expression of VDR target genes and serum calcium levels in 1α,25(OH)2D3-intoxicated mice. As ZK168281 also blunts 1α,25(OH)2D3-induced VDR signaling in fibroblasts of a patient with impaired vitamin D degradation, this VDR antagonist represents a promising therapeutic option for 1α,25(OH)2D3-induced hypercalcemia.
Suggested Citation
Daniela Rovito & Anna Y. Belorusova & Sandra Chalhoub & Anna-Isavella Rerra & Elvire Guiot & Arnaud Molin & Agnès Linglart & Natacha Rochel & Gilles Laverny & Daniel Metzger, 2020.
"Cytosolic sequestration of the vitamin D receptor as a therapeutic option for vitamin D-induced hypercalcemia,"
Nature Communications, Nature, vol. 11(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-20069-4
DOI: 10.1038/s41467-020-20069-4
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-20069-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.